Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...

Discover how Unicorn Biotechnologies is revolutionizing lab workflows with cell culture automation. Expert insights from ...

Bucks County Community College officials announced that Lisa Burgess will join the College’s vibrant community of scholars to lead the School of Science, ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

The International Society for Stem Cell Research (ISSCR) announces the launch of a new online continuing education course, ...

BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that it has signed a Letter of Intent (LOI) with Minaris Advanced ...

Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...

Dystrophic epidermolysis bullosa (DEB) is one of the main subtypes of epidermolysis bullosa, a group of genetic skin ...

Key market opportunities in the Plant Stem Cell Market include leveraging the consumer shift toward natural and sustainable products, especially in cosmetics and healthcare, driving demand with ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Albert Einstein College of Medicine has appointed Britta Will, Ph.D., associate professor of oncology, of medicine and of cell biology, and the Diane and Arthur B. Belfer Scholar in Cancer Research, ...

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.